The global Platelet-rich Plasma Therapy market was valued at US$ 722 million in 2023 and is anticipated to reach US$ 1919.8 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.

Platelet-rich Plasma Therapy Market

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Platelet-rich Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platelet-rich Plasma Therapy.

Report Scope

The Platelet-rich Plasma Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platelet-rich Plasma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Platelet-rich Plasma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Platelet-rich Plasma Therapy Market Report

Report Metric	Details
Report Name	Platelet-rich Plasma Therapy Market
Accounted market size in 2023	US$ 722 million
Forecasted market size in 2030	US$ 1919.8 million
CAGR	15.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Pure PRP Leucocyte-rich PRP Leukocyte-rich Fibrin (L-PRF)
Segment by Application	Orthopedic Darmatology Cardiac Muscle Injury Dental Nerve Injury Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Terumo, Arthrex, Zimmer Biomet, J & J, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Platelet-rich Plasma Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Platelet-rich Plasma Therapy Market growing?

Ans: The Platelet-rich Plasma Therapy Market witnessing a CAGR of 15.0% during the forecast period 2024-2030.

What is the Platelet-rich Plasma Therapy Market size in 2030?

Ans: The Platelet-rich Plasma Therapy Market size in 2030 will be US$ 1919.8 million.

Who are the main players in the Platelet-rich Plasma Therapy Market report?

Ans: The main players in the Platelet-rich Plasma Therapy Market are Terumo, Arthrex, Zimmer Biomet, J & J, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics

What are the Application segmentation covered in the Platelet-rich Plasma Therapy Market report?

Ans: The Applications covered in the Platelet-rich Plasma Therapy Market report are Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Others

What are the Type segmentation covered in the Platelet-rich Plasma Therapy Market report?

Ans: The Types covered in the Platelet-rich Plasma Therapy Market report are Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Platelet-rich Plasma Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Pure PRP

1.2.3 Leucocyte-rich PRP

1.2.4 Leukocyte-rich Fibrin (L-PRF)

1.3 Market by Application

1.3.1 Global Platelet-rich Plasma Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Orthopedic

1.3.3 Darmatology

1.3.4 Cardiac Muscle Injury

1.3.5 Dental

1.3.6 Nerve Injury

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Platelet-rich Plasma Therapy Market Perspective (2019-2030)

2.2 Platelet-rich Plasma Therapy Growth Trends by Region

2.2.1 Global Platelet-rich Plasma Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Platelet-rich Plasma Therapy Historic Market Size by Region (2019-2024)

2.2.3 Platelet-rich Plasma Therapy Forecasted Market Size by Region (2025-2030)

2.3 Platelet-rich Plasma Therapy Market Dynamics

2.3.1 Platelet-rich Plasma Therapy Industry Trends

2.3.2 Platelet-rich Plasma Therapy Market Drivers

2.3.3 Platelet-rich Plasma Therapy Market Challenges

2.3.4 Platelet-rich Plasma Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Platelet-rich Plasma Therapy Players by Revenue

3.1.1 Global Top Platelet-rich Plasma Therapy Players by Revenue (2019-2024)

3.1.2 Global Platelet-rich Plasma Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Platelet-rich Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Platelet-rich Plasma Therapy Revenue

3.4 Global Platelet-rich Plasma Therapy Market Concentration Ratio

3.4.1 Global Platelet-rich Plasma Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Platelet-rich Plasma Therapy Revenue in 2023

3.5 Platelet-rich Plasma Therapy Key Players Head office and Area Served

3.6 Key Players Platelet-rich Plasma Therapy Product Solution and Service

3.7 Date of Enter into Platelet-rich Plasma Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Platelet-rich Plasma Therapy Breakdown Data by Type

4.1 Global Platelet-rich Plasma Therapy Historic Market Size by Type (2019-2024)

4.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Type (2025-2030)

5 Platelet-rich Plasma Therapy Breakdown Data by Application

5.1 Global Platelet-rich Plasma Therapy Historic Market Size by Application (2019-2024)

5.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Platelet-rich Plasma Therapy Market Size (2019-2030)

6.2 North America Platelet-rich Plasma Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Platelet-rich Plasma Therapy Market Size by Country (2019-2024)

6.4 North America Platelet-rich Plasma Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Platelet-rich Plasma Therapy Market Size (2019-2030)

7.2 Europe Platelet-rich Plasma Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Platelet-rich Plasma Therapy Market Size by Country (2019-2024)

7.4 Europe Platelet-rich Plasma Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size (2019-2030)

8.2 Asia-Pacific Platelet-rich Plasma Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Platelet-rich Plasma Therapy Market Size (2019-2030)

9.2 Latin America Platelet-rich Plasma Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Platelet-rich Plasma Therapy Market Size by Country (2019-2024)

9.4 Latin America Platelet-rich Plasma Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size (2019-2030)

10.2 Middle East & Africa Platelet-rich Plasma Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Terumo

11.1.1 Terumo Company Detail

11.1.2 Terumo Business Overview

11.1.3 Terumo Platelet-rich Plasma Therapy Introduction

11.1.4 Terumo Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.1.5 Terumo Recent Development

11.2 Arthrex

11.2.1 Arthrex Company Detail

11.2.2 Arthrex Business Overview

11.2.3 Arthrex Platelet-rich Plasma Therapy Introduction

11.2.4 Arthrex Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.2.5 Arthrex Recent Development

11.3 Zimmer Biomet

11.3.1 Zimmer Biomet Company Detail

11.3.2 Zimmer Biomet Business Overview

11.3.3 Zimmer Biomet Platelet-rich Plasma Therapy Introduction

11.3.4 Zimmer Biomet Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.3.5 Zimmer Biomet Recent Development

11.4 J & J

11.4.1 J & J Company Detail

11.4.2 J & J Business Overview

11.4.3 J & J Platelet-rich Plasma Therapy Introduction

11.4.4 J & J Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.4.5 J & J Recent Development

11.5 EmCyte

11.5.1 EmCyte Company Detail

11.5.2 EmCyte Business Overview

11.5.3 EmCyte Platelet-rich Plasma Therapy Introduction

11.5.4 EmCyte Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.5.5 EmCyte Recent Development

11.6 Regen Lab

11.6.1 Regen Lab Company Detail

11.6.2 Regen Lab Business Overview

11.6.3 Regen Lab Platelet-rich Plasma Therapy Introduction

11.6.4 Regen Lab Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.6.5 Regen Lab Recent Development

11.7 ISTO Biologics

11.7.1 ISTO Biologics Company Detail

11.7.2 ISTO Biologics Business Overview

11.7.3 ISTO Biologics Platelet-rich Plasma Therapy Introduction

11.7.4 ISTO Biologics Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.7.5 ISTO Biologics Recent Development

11.8 Cesca Therapeutics

11.8.1 Cesca Therapeutics Company Detail

11.8.2 Cesca Therapeutics Business Overview

11.8.3 Cesca Therapeutics Platelet-rich Plasma Therapy Introduction

11.8.4 Cesca Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.8.5 Cesca Therapeutics Recent Development

11.9 Weigao

11.9.1 Weigao Company Detail

11.9.2 Weigao Business Overview

11.9.3 Weigao Platelet-rich Plasma Therapy Introduction

11.9.4 Weigao Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.9.5 Weigao Recent Development

11.10 REV-MED

11.10.1 REV-MED Company Detail

11.10.2 REV-MED Business Overview

11.10.3 REV-MED Platelet-rich Plasma Therapy Introduction

11.10.4 REV-MED Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.10.5 REV-MED Recent Development

11.11 Nuo Therapeutics

11.11.1 Nuo Therapeutics Company Detail

11.11.2 Nuo Therapeutics Business Overview

11.11.3 Nuo Therapeutics Platelet-rich Plasma Therapy Introduction

11.11.4 Nuo Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2019-2024)

11.11.5 Nuo Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Platelet-rich Plasma Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Pure PRP

Table 3. Key Players of Leucocyte-rich PRP

Table 4. Key Players of Leukocyte-rich Fibrin (L-PRF)

Table 5. Global Platelet-rich Plasma Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Platelet-rich Plasma Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Platelet-rich Plasma Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Platelet-rich Plasma Therapy Market Share by Region (2019-2024)

Table 9. Global Platelet-rich Plasma Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Platelet-rich Plasma Therapy Market Share by Region (2025-2030)

Table 11. Platelet-rich Plasma Therapy Market Trends

Table 12. Platelet-rich Plasma Therapy Market Drivers

Table 13. Platelet-rich Plasma Therapy Market Challenges

Table 14. Platelet-rich Plasma Therapy Market Restraints

Table 15. Global Platelet-rich Plasma Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Platelet-rich Plasma Therapy Market Share by Players (2019-2024)

Table 17. Global Top Platelet-rich Plasma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platelet-rich Plasma Therapy as of 2023)

Table 18. Ranking of Global Top Platelet-rich Plasma Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Platelet-rich Plasma Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Platelet-rich Plasma Therapy Product Solution and Service

Table 22. Date of Enter into Platelet-rich Plasma Therapy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Platelet-rich Plasma Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Platelet-rich Plasma Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Platelet-rich Plasma Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Platelet-rich Plasma Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Platelet-rich Plasma Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Platelet-rich Plasma Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Platelet-rich Plasma Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Platelet-rich Plasma Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Platelet-rich Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Platelet-rich Plasma Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Platelet-rich Plasma Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Platelet-rich Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Platelet-rich Plasma Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Platelet-rich Plasma Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Platelet-rich Plasma Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Platelet-rich Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Platelet-rich Plasma Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Platelet-rich Plasma Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Platelet-rich Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Terumo Company Detail

Table 48. Terumo Business Overview

Table 49. Terumo Platelet-rich Plasma Therapy Product

Table 50. Terumo Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 51. Terumo Recent Development

Table 52. Arthrex Company Detail

Table 53. Arthrex Business Overview

Table 54. Arthrex Platelet-rich Plasma Therapy Product

Table 55. Arthrex Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 56. Arthrex Recent Development

Table 57. Zimmer Biomet Company Detail

Table 58. Zimmer Biomet Business Overview

Table 59. Zimmer Biomet Platelet-rich Plasma Therapy Product

Table 60. Zimmer Biomet Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 61. Zimmer Biomet Recent Development

Table 62. J & J Company Detail

Table 63. J & J Business Overview

Table 64. J & J Platelet-rich Plasma Therapy Product

Table 65. J & J Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 66. J & J Recent Development

Table 67. EmCyte Company Detail

Table 68. EmCyte Business Overview

Table 69. EmCyte Platelet-rich Plasma Therapy Product

Table 70. EmCyte Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 71. EmCyte Recent Development

Table 72. Regen Lab Company Detail

Table 73. Regen Lab Business Overview

Table 74. Regen Lab Platelet-rich Plasma Therapy Product

Table 75. Regen Lab Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 76. Regen Lab Recent Development

Table 77. ISTO Biologics Company Detail

Table 78. ISTO Biologics Business Overview

Table 79. ISTO Biologics Platelet-rich Plasma Therapy Product

Table 80. ISTO Biologics Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 81. ISTO Biologics Recent Development

Table 82. Cesca Therapeutics Company Detail

Table 83. Cesca Therapeutics Business Overview

Table 84. Cesca Therapeutics Platelet-rich Plasma Therapy Product

Table 85. Cesca Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 86. Cesca Therapeutics Recent Development

Table 87. Weigao Company Detail

Table 88. Weigao Business Overview

Table 89. Weigao Platelet-rich Plasma Therapy Product

Table 90. Weigao Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 91. Weigao Recent Development

Table 92. REV-MED Company Detail

Table 93. REV-MED Business Overview

Table 94. REV-MED Platelet-rich Plasma Therapy Product

Table 95. REV-MED Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 96. REV-MED Recent Development

Table 97. Nuo Therapeutics Company Detail

Table 98. Nuo Therapeutics Business Overview

Table 99. Nuo Therapeutics Platelet-rich Plasma Therapy Product

Table 100. Nuo Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2019-2024) & (US$ Million)

Table 101. Nuo Therapeutics Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Platelet-rich Plasma Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Platelet-rich Plasma Therapy Market Share by Type: 2023 VS 2030

Figure 3. Pure PRP Features

Figure 4. Leucocyte-rich PRP Features

Figure 5. Leukocyte-rich Fibrin (L-PRF) Features

Figure 6. Global Platelet-rich Plasma Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Platelet-rich Plasma Therapy Market Share by Application: 2023 VS 2030

Figure 8. Orthopedic Case Studies

Figure 9. Darmatology Case Studies

Figure 10. Cardiac Muscle Injury Case Studies

Figure 11. Dental Case Studies

Figure 12. Nerve Injury Case Studies

Figure 13. Others Case Studies

Figure 14. Platelet-rich Plasma Therapy Report Years Considered

Figure 15. Global Platelet-rich Plasma Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Platelet-rich Plasma Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Platelet-rich Plasma Therapy Market Share by Region: 2023 VS 2030

Figure 18. Global Platelet-rich Plasma Therapy Market Share by Players in 2023

Figure 19. Global Top Platelet-rich Plasma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platelet-rich Plasma Therapy as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Platelet-rich Plasma Therapy Revenue in 2023

Figure 21. North America Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Platelet-rich Plasma Therapy Market Share by Country (2019-2030)

Figure 23. United States Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Platelet-rich Plasma Therapy Market Share by Country (2019-2030)

Figure 27. Germany Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Platelet-rich Plasma Therapy Market Share by Region (2019-2030)

Figure 35. China Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Platelet-rich Plasma Therapy Market Share by Country (2019-2030)

Figure 43. Mexico Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Platelet-rich Plasma Therapy Market Share by Country (2019-2030)

Figure 47. Turkey Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Platelet-rich Plasma Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Terumo Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 50. Arthrex Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 51. Zimmer Biomet Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 52. J & J Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 53. EmCyte Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 54. Regen Lab Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 55. ISTO Biologics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 56. Cesca Therapeutics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 57. Weigao Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 58. REV-MED Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 59. Nuo Therapeutics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Liquid Biopsy Technology Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-30J12611

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Pulsed Electromagnetic Field Therapy (PEMF) Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-26S14908

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Bio Surgery (Biosurgery) Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29C6857

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Angiographic Contrast Medium Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-11X15373

Fri May 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions